Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biqi capsule with or without diclofenac for discogenic low back pain
ChiCTR2400084447Phase 4Recruiting
- Sponsor
- Tianjin Hospital
- Start
- May 2024
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Biqi Capsule and diclofenac in discogenic back pain (3 arms), sponsored by Tianjin Hospital. Primary endpoint: VAS scores. Started May 2024; status: recruiting.
02
Drugs
Biqi Capsulediclofenac
03
Conditions
discogenic back pain
Beyond the preview
Go deeper on ChiCTR2400084447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084447.